BETTUZZI, Thomas et al. Evolution of Drug Survival with Biological Agents and Apremilast Between 2012 and 2018 in Patients with Psoriasis from the PsoBioTeq Cohort. Acta Dermato-Venereologica, [S. l.], v. 102, p. adv00665, 2022. DOI: 10.2340/actadv.v101.566. Disponível em: https://medicaljournalssweden.se/actadv/article/view/566. Acesso em: 21 sep. 2024.